Zu‐Lu Ye

447 total citations
24 papers, 277 citations indexed

About

Zu‐Lu Ye is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zu‐Lu Ye has authored 24 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Zu‐Lu Ye's work include Genetic factors in colorectal cancer (4 papers), RNA modifications and cancer (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Zu‐Lu Ye is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), RNA modifications and cancer (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Zu‐Lu Ye collaborates with scholars based in China, United States and Sweden. Zu‐Lu Ye's co-authors include Caiyun He, Da‐Lei Zhou, Xuan Su, Jian‐Yong Shao, Tao Tang, Jiangjun Ma, Miao‐Zhen Qiu, Hong An, Xinhua Yang and Fang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zu‐Lu Ye

24 papers receiving 275 citations

Peers

Zu‐Lu Ye
Anne‐Katrin Zimmermann Switzerland
Yang Mh Taiwan
Chun Jin China
Kyung-Ju Kim South Korea
Xiangshan Yang China
N.G. Shah India
Changjiang Qin China
Hiroaki Shima Japan
Simona Tortorella Italy
Changyoung Yoo South Korea
Anne‐Katrin Zimmermann Switzerland
Zu‐Lu Ye
Citations per year, relative to Zu‐Lu Ye Zu‐Lu Ye (= 1×) peers Anne‐Katrin Zimmermann

Countries citing papers authored by Zu‐Lu Ye

Since Specialization
Citations

This map shows the geographic impact of Zu‐Lu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐Lu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐Lu Ye more than expected).

Fields of papers citing papers by Zu‐Lu Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐Lu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐Lu Ye. The network helps show where Zu‐Lu Ye may publish in the future.

Co-authorship network of co-authors of Zu‐Lu Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐Lu Ye. A scholar is included among the top collaborators of Zu‐Lu Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐Lu Ye. Zu‐Lu Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Xuan, Da‐Lei Zhou, Qing Liu, et al.. (2022). A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Molecular Therapy — Nucleic Acids. 28. 408–422. 10 indexed citations
2.
Li, Yue, Da‐Lei Zhou, Qing Liu, et al.. (2022). Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer. Pharmacogenomics and Personalized Medicine. Volume 15. 547–559. 9 indexed citations
3.
Yang, Xinhua, et al.. (2022). Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers. Gene. 814. 146157–146157. 4 indexed citations
4.
Su, Xuan, Huichan He, Zu‐Lu Ye, et al.. (2020). A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers. Frontiers in Oncology. 10. 535893–535893. 10 indexed citations
5.
Su, Xuan, Da‐Lei Zhou, Zu‐Lu Ye, et al.. (2020). Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer. Genomics. 112(6). 4959–4967. 10 indexed citations
6.
7.
Xu, Fei, et al.. (2020). Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma. Neoplasma. 68(1). 62–70. 7 indexed citations
8.
Li, Yue, Huichan He, Da‐Lei Zhou, et al.. (2020). Associations between lncRNA‐related polymorphisms and hepatocellular carcinoma risk: A two‐stage case–control study. Journal of Gastroenterology and Hepatology. 36(1). 233–239. 2 indexed citations
9.
Gong, Rui, Yuan He, Xiaoyun Liu, et al.. (2019). <p>Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients</p>. Cancer Management and Research. Volume 11. 3721–3739. 18 indexed citations
10.
He, Yuan, Tao Tang, Ling Deng, et al.. (2019). Prognostic Implications of Tripartite Motif Containing 24 Expression Levels in Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Genetic Testing and Molecular Biomarkers. 23(7). 473–479. 3 indexed citations
11.
Su, Xuan, Da‐Lei Zhou, Zu‐Lu Ye, et al.. (2019). A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Mutation Research/Reviews in Mutation Research. 779. 45–57. 33 indexed citations
12.
Su, Xuan, Shu-Wei Chen, Xinhua Yang, et al.. (2019). TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer. Cancer Biomarkers. 26(4). 461–470. 4 indexed citations
13.
Ye, Zu‐Lu, Miao‐Zhen Qiu, Tao Tang, et al.. (2019). Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis. Cancer Medicine. 9(2). 745–756. 31 indexed citations
14.
15.
Chen, Le-Zong, Xuan Su, Dong-liang Chen, et al.. (2017). SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility. Gene. 640. 43–50. 15 indexed citations
16.
He, Caiyun, Jiangjun Ma, Xuan Su, et al.. (2017). Associations between RET tagSNPs and their haplotypes and susceptibility, clinical severity, and thyroid function in patients with differentiated thyroid cancer. PLoS ONE. 12(11). e0187968–e0187968. 2 indexed citations
17.
18.
Ye, Zu‐Lu, et al.. (2015). A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis. Scientific Reports. 5(1). 13595–13595. 33 indexed citations
19.
Fu, Sha, Haiyun Wang, Fang Wang, et al.. (2015). Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement. Chinese Journal of Cancer. 34(3). 404–12. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Katrin Zimmermann Breakdown of academic impact, for papers by Yang Mh Breakdown of academic impact, for papers by Chun Jin Breakdown of academic impact, for papers by Kyung-Ju Kim Breakdown of academic impact, for papers by Xiangshan Yang Breakdown of academic impact, for papers by N.G. Shah Breakdown of academic impact, for papers by Changjiang Qin Breakdown of academic impact, for papers by Hiroaki Shima Breakdown of academic impact, for papers by Simona Tortorella Breakdown of academic impact, for papers by Changyoung Yoo
Rankless by CCL
2026